The Faustman Lab made some announcements regarding the phase II of the BCG trial. I quote: "Foremost, the Phase II BCG human clinical trial is now underway. We received FDA approval in June to start the clinical trial and we are currently enrolling and treating patients." Those who care to follow the lab activities might want to visit its website (www.faustman.org) and the latest newsletter (http://files.ctctcdn.com/cc14a99f001/f7e5fb61-aaf7-4ce0-95e4-3dd72afaada7.pdf)